Stay updated on Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new page revision tag (v3.6.6) appears, replacing the previous v3.6.5. This signals an update to the page's metadata rather than any changes to the study content.
    Difference
    0.0%
    Check dated 2026-09-01T19:01:18.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision label updated to v3.6.5, replacing the previous v3.6.4. This reflects a small maintenance update to the site's revision history and does not change the study content.
    Difference
    0.0%
    Check dated 2026-08-11T17:51:35.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a new page version. No study details or eligibility criteria are changed by this update.
    Difference
    0.0%
    Check dated 2026-07-28T12:15:37.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.2 to v3.6.3, signaling a minor update to the page template or underlying system.
    Difference
    0.0%
    Check dated 2026-07-07T02:40:48.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.6.0 to v3.6.2, indicating a maintenance/template update to the page. No changes to study details, eligibility criteria, or results are reflected.
    Difference
    0.0%
    Check dated 2026-06-29T17:47:43.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page now signals that it is no longer seeking participants, and adds new user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) with a reformatting of the Intervention/Treatment label and an updated revision stamp from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T08:37:36.000Z thumbnail image

Stay in the know with updates to Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.